Bacterial-Derived Outer Membrane Vesicles Are Potent Adjuvants That Drive Humoral and Cellular Immune Responses
Discovery and development of novel adjuvants that can improve existing or next generation vaccine platforms have received considerable interest in recent years. In particular, adjuvants that can elicit both humoral and cellular immune responses would be particularly advantageous because the majority...
Main Authors: | J. Timothy Prior, Christopher Davitt, Jonathan Kurtz, Patrick Gellings, James B. McLachlan, Lisa A. Morici |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/131 |
Similar Items
-
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
by: Kuang Tan, et al.
Published: (2018-04-01) -
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants
by: Mohammadali Malekan, et al.
Published: (2019-12-01) -
Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains
by: DineshKumar Kesavan, et al.
Published: (2020-02-01) -
Surface Exposure and Packing of Lipoproteins into Outer Membrane Vesicles Are Coupled Processes in Bacteroides
by: Ezequiel Valguarnera, et al.
Published: (2018-11-01) -
Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01)